Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Cyclophosphamide Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

  • MAI4669597
  • 125 Pages
  • November 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Cyclophosphamide is a drug used as a chemotherapy and immune system.

Based on the Cyclophosphamide market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.

In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.

In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Cyclophosphamide market covered in Chapter 5:

Roxane

Pfizer

Merck

LGM Pharma

Allergan

The Medicines Company

Theravance Biopharma

Sanofi

GLS Pharma Ltd

Basilea Pharmaceutica

Baxter

In Chapter 6, on the basis of types, the Cyclophosphamide market from 2015 to 2025 is primarily split into:

Cyclophosphamide Powder

Cyclophosphamide Injection

In Chapter 7, on the basis of applications, the Cyclophosphamide market from 2015 to 2025 covers:

Malignant Lymphoma

Multiple Myeloma

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:

North America (Covered in Chapter 9)

United States

Canada

Mexico

Europe (Covered in Chapter 10)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 11)

China

Japan

South Korea

Australia

India

South America (Covered in Chapter 12)

Brazil

Argentina

Columbia

Middle East and Africa (Covered in Chapter 13)

UAE

Egypt

South Africa

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content

1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global Cyclophosphamide Market Size

1.3 Market Segmentation

1.4 Global Macroeconomic Analysis

1.5 SWOT Analysis

2. Market Dynamics

2.1 Market Drivers

2.2 Market Constraints and Challenges

2.3 Emerging Market Trends

2.4 Impact of COVID-19

2.4.1 Short-term Impact

2.4.2 Long-term Impact

3 Associated Industry Assessment

3.1 Supply Chain Analysis

3.2 Industry Active Participants

3.2.1 Suppliers of Raw Materials

3.2.2 Key Distributors/Retailers

3.3 Alternative Analysis

3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

4.1 Industry Leading Players

4.2 Industry News

4.2.1 Key Product Launch News

4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

5.1 Roxane

5.1.1 Roxane Company Profile

5.1.2 Roxane Business Overview

5.1.3 Roxane Cyclophosphamide Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.1.4 Roxane Cyclophosphamide Products Introduction

5.2 Pfizer

5.2.1 Pfizer Company Profile

5.2.2 Pfizer Business Overview

5.2.3 Pfizer Cyclophosphamide Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.2.4 Pfizer Cyclophosphamide Products Introduction

5.3 Merck

5.3.1 Merck Company Profile

5.3.2 Merck Business Overview

5.3.3 Merck Cyclophosphamide Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.3.4 Merck Cyclophosphamide Products Introduction

5.4 LGM Pharma

5.4.1 LGM Pharma Company Profile

5.4.2 LGM Pharma Business Overview

5.4.3 LGM Pharma Cyclophosphamide Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.4.4 LGM Pharma Cyclophosphamide Products Introduction

5.5 Allergan

5.5.1 Allergan Company Profile

5.5.2 Allergan Business Overview

5.5.3 Allergan Cyclophosphamide Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.5.4 Allergan Cyclophosphamide Products Introduction

5.6 The Medicines Company

5.6.1 The Medicines Company Company Profile

5.6.2 The Medicines Company Business Overview

5.6.3 The Medicines Company Cyclophosphamide Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.6.4 The Medicines Company Cyclophosphamide Products Introduction

5.7 Theravance Biopharma

5.7.1 Theravance Biopharma Company Profile

5.7.2 Theravance Biopharma Business Overview

5.7.3 Theravance Biopharma Cyclophosphamide Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.7.4 Theravance Biopharma Cyclophosphamide Products Introduction

5.8 Sanofi

5.8.1 Sanofi Company Profile

5.8.2 Sanofi Business Overview

5.8.3 Sanofi Cyclophosphamide Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.8.4 Sanofi Cyclophosphamide Products Introduction

5.9 GLS Pharma Ltd

5.9.1 GLS Pharma Ltd Company Profile

5.9.2 GLS Pharma Ltd Business Overview

5.9.3 GLS Pharma Ltd Cyclophosphamide Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.9.4 GLS Pharma Ltd Cyclophosphamide Products Introduction

5.10 Basilea Pharmaceutica

5.10.1 Basilea Pharmaceutica Company Profile

5.10.2 Basilea Pharmaceutica Business Overview

5.10.3 Basilea Pharmaceutica Cyclophosphamide Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.10.4 Basilea Pharmaceutica Cyclophosphamide Products Introduction

5.11 Baxter

5.11.1 Baxter Company Profile

5.11.2 Baxter Business Overview

5.11.3 Baxter Cyclophosphamide Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.11.4 Baxter Cyclophosphamide Products Introduction

6 Market Analysis and Forecast, By Product Types

6.1 Global Cyclophosphamide Sales, Revenue and Market Share by Types (2015-2020)

6.1.1 Global Cyclophosphamide Sales and Market Share by Types (2015-2020)

6.1.2 Global Cyclophosphamide Revenue and Market Share by Types (2015-2020)

6.1.3 Global Cyclophosphamide Price by Types (2015-2020)

6.2 Global Cyclophosphamide Market Forecast by Types (2020-2025)

6.2.1 Global Cyclophosphamide Market Forecast Sales and Market Share by Types (2020-2025)

6.2.2 Global Cyclophosphamide Market Forecast Revenue and Market Share by Types (2020-2025)

6.3 Global Cyclophosphamide Sales, Price and Growth Rate by Types (2015-2020)

6.3.1 Global Cyclophosphamide Sales, Price and Growth Rate of Cyclophosphamide Powder

6.3.2 Global Cyclophosphamide Sales, Price and Growth Rate of Cyclophosphamide Injection

6.4 Global Cyclophosphamide Market Revenue and Sales Forecast, by Types (2020-2025)

6.4.1 Cyclophosphamide Powder Market Revenue and Sales Forecast (2020-2025)

6.4.2 Cyclophosphamide Injection Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

7.1 Global Cyclophosphamide Sales, Revenue and Market Share by Applications (2015-2020)

7.1.1 Global Cyclophosphamide Sales and Market Share by Applications (2015-2020)

7.1.2 Global Cyclophosphamide Revenue and Market Share by Applications (2015-2020)

7.2 Global Cyclophosphamide Market Forecast by Applications (2020-2025)

7.2.1 Global Cyclophosphamide Market Forecast Sales and Market Share by Applications (2020-2025)

7.2.2 Global Cyclophosphamide Market Forecast Revenue and Market Share by Applications (2020-2025)

7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)

7.3.1 Global Cyclophosphamide Revenue, Sales and Growth Rate of Malignant Lymphoma (2015-2020)

7.3.2 Global Cyclophosphamide Revenue, Sales and Growth Rate of Multiple Myeloma (2015-2020)

7.4 Global Cyclophosphamide Market Revenue and Sales Forecast, by Applications (2020-2025)

7.4.1 Malignant Lymphoma Market Revenue and Sales Forecast (2020-2025)

7.4.2 Multiple Myeloma Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

8.1 Global Cyclophosphamide Sales by Regions (2015-2020)

8.2 Global Cyclophosphamide Market Revenue by Regions (2015-2020)

8.3 Global Cyclophosphamide Market Forecast by Regions (2020-2025)

9 North America Cyclophosphamide Market Analysis

9.1 Market Overview and Prospect Analysis

9.2 North America Cyclophosphamide Market Sales and Growth Rate (2015-2020)

9.3 North America Cyclophosphamide Market Revenue and Growth Rate (2015-2020)

9.4 North America Cyclophosphamide Market Forecast

9.5 The Influence of COVID-19 on North America Market

9.6 North America Cyclophosphamide Market Analysis by Country

9.6.1 U.S. Cyclophosphamide Sales and Growth Rate

9.6.2 Canada Cyclophosphamide Sales and Growth Rate

9.6.3 Mexico Cyclophosphamide Sales and Growth Rate

10 Europe Cyclophosphamide Market Analysis

10.1 Market Overview and Prospect Analysis

10.2 Europe Cyclophosphamide Market Sales and Growth Rate (2015-2020)

10.3 Europe Cyclophosphamide Market Revenue and Growth Rate (2015-2020)

10.4 Europe Cyclophosphamide Market Forecast

10.5 The Influence of COVID-19 on Europe Market

10.6 Europe Cyclophosphamide Market Analysis by Country

10.6.1 Germany Cyclophosphamide Sales and Growth Rate

10.6.2 United Kingdom Cyclophosphamide Sales and Growth Rate

10.6.3 France Cyclophosphamide Sales and Growth Rate

10.6.4 Italy Cyclophosphamide Sales and Growth Rate

10.6.5 Spain Cyclophosphamide Sales and Growth Rate

10.6.6 Russia Cyclophosphamide Sales and Growth Rate

11 Asia-Pacific Cyclophosphamide Market Analysis

11.1 Market Overview and Prospect Analysis

11.2 Asia-Pacific Cyclophosphamide Market Sales and Growth Rate (2015-2020)

11.3 Asia-Pacific Cyclophosphamide Market Revenue and Growth Rate (2015-2020)

11.4 Asia-Pacific Cyclophosphamide Market Forecast

11.5 The Influence of COVID-19 on Asia Pacific Market

11.6 Asia-Pacific Cyclophosphamide Market Analysis by Country

11.6.1 China Cyclophosphamide Sales and Growth Rate

11.6.2 Japan Cyclophosphamide Sales and Growth Rate

11.6.3 South Korea Cyclophosphamide Sales and Growth Rate

11.6.4 Australia Cyclophosphamide Sales and Growth Rate

11.6.5 India Cyclophosphamide Sales and Growth Rate

12 South America Cyclophosphamide Market Analysis

12.1 Market Overview and Prospect Analysis

12.2 South America Cyclophosphamide Market Sales and Growth Rate (2015-2020)

12.3 South America Cyclophosphamide Market Revenue and Growth Rate (2015-2020)

12.4 South America Cyclophosphamide Market Forecast

12.5 The Influence of COVID-19 on South America Market

12.6 South America Cyclophosphamide Market Analysis by Country

12.6.1 Brazil Cyclophosphamide Sales and Growth Rate

12.6.2 Argentina Cyclophosphamide Sales and Growth Rate

12.6.3 Columbia Cyclophosphamide Sales and Growth Rate

13 Middle East and Africa Cyclophosphamide Market Analysis

13.1 Market Overview and Prospect Analysis

13.2 Middle East and Africa Cyclophosphamide Market Sales and Growth Rate (2015-2020)

13.3 Middle East and Africa Cyclophosphamide Market Revenue and Growth Rate (2015-2020)

13.4 Middle East and Africa Cyclophosphamide Market Forecast

13.5 The Influence of COVID-19 on Middle East and Africa Market

13.6 Middle East and Africa Cyclophosphamide Market Analysis by Country

13.6.1 UAE Cyclophosphamide Sales and Growth Rate

13.6.2 Egypt Cyclophosphamide Sales and Growth Rate

13.6.3 South Africa Cyclophosphamide Sales and Growth Rate

14 Conclusions and Recommendations

14.1 Key Market Findings and Prospects

14.2 Advice for Investors

15 Appendix

15.1 Methodology

15.2 Research Data Source

List of Tables and Figures

Figure Product Picture

Figure Global Cyclophosphamide Market Size and Growth Rate 2015-2025

Table Cyclophosphamide Key Market Segments

Figure Global Cyclophosphamide Market Revenue ($) Segment by Type from 2015-2020

Figure Global Cyclophosphamide Market Revenue ($) Segment by Applications from 2015-2020

Table SWOT Analysis

Figure Global COVID-19 Status

Figure Supply Chain

Table Major Players Headquarters, and Service Area of Cyclophosphamide

Table Major Players Revenue in 2019

Figure Major Players Revenue Share in 2019

Table Roxane Company Profile

Table Roxane Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Roxane Production and Growth Rate

Figure Roxane Market Revenue ($) Market Share 2015-2020

Table Pfizer Company Profile

Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Pfizer Production and Growth Rate

Figure Pfizer Market Revenue ($) Market Share 2015-2020

Table Merck Company Profile

Table Merck Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Merck Production and Growth Rate

Figure Merck Market Revenue ($) Market Share 2015-2020

Table LGM Pharma Company Profile

Table LGM Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure LGM Pharma Production and Growth Rate

Figure LGM Pharma Market Revenue ($) Market Share 2015-2020

Table Allergan Company Profile

Table Allergan Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Allergan Production and Growth Rate

Figure Allergan Market Revenue ($) Market Share 2015-2020

Table The Medicines Company Company Profile

Table The Medicines Company Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure The Medicines Company Production and Growth Rate

Figure The Medicines Company Market Revenue ($) Market Share 2015-2020

Table Theravance Biopharma Company Profile

Table Theravance Biopharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Theravance Biopharma Production and Growth Rate

Figure Theravance Biopharma Market Revenue ($) Market Share 2015-2020

Table Sanofi Company Profile

Table Sanofi Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Sanofi Production and Growth Rate

Figure Sanofi Market Revenue ($) Market Share 2015-2020

Table GLS Pharma Ltd Company Profile

Table GLS Pharma Ltd Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure GLS Pharma Ltd Production and Growth Rate

Figure GLS Pharma Ltd Market Revenue ($) Market Share 2015-2020

Table Basilea Pharmaceutica Company Profile

Table Basilea Pharmaceutica Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Basilea Pharmaceutica Production and Growth Rate

Figure Basilea Pharmaceutica Market Revenue ($) Market Share 2015-2020

Table Baxter Company Profile

Table Baxter Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Baxter Production and Growth Rate

Figure Baxter Market Revenue ($) Market Share 2015-2020

Table Global Cyclophosphamide Sales by Types (2015-2020)

Table Global Cyclophosphamide Sales Share by Types (2015-2020)

Table Global Cyclophosphamide Revenue ($) by Types (2015-2020)

Table Global Cyclophosphamide Revenue Share by Types (2015-2020)

Table Global Cyclophosphamide Price ($) by Types (2015-2020)

Table Global Cyclophosphamide Market Forecast Sales by Types (2020-2025)

Table Global Cyclophosphamide Market Forecast Sales Share by Types (2020-2025)

Table Global Cyclophosphamide Market Forecast Revenue ($) by Types (2020-2025)

Table Global Cyclophosphamide Market Forecast Revenue Share by Types (2020-2025)

Figure Global Cyclophosphamide Powder Sales and Growth Rate (2015-2020)

Figure Global Cyclophosphamide Powder Price (2015-2020)

Figure Global Cyclophosphamide Injection Sales and Growth Rate (2015-2020)

Figure Global Cyclophosphamide Injection Price (2015-2020)

Figure Global Cyclophosphamide Market Revenue ($) and Growth Rate Forecast of Cyclophosphamide Powder (2020-2025)

Figure Global Cyclophosphamide Sales and Growth Rate Forecast of Cyclophosphamide Powder (2020-2025)

Figure Global Cyclophosphamide Market Revenue ($) and Growth Rate Forecast of Cyclophosphamide Injection (2020-2025)

Figure Global Cyclophosphamide Sales and Growth Rate Forecast of Cyclophosphamide Injection (2020-2025)

Table Global Cyclophosphamide Sales by Applications (2015-2020)

Table Global Cyclophosphamide Sales Share by Applications (2015-2020)

Table Global Cyclophosphamide Revenue ($) by Applications (2015-2020)

Table Global Cyclophosphamide Revenue Share by Applications (2015-2020)

Table Global Cyclophosphamide Market Forecast Sales by Applications (2020-2025)

Table Global Cyclophosphamide Market Forecast Sales Share by Applications (2020-2025)

Table Global Cyclophosphamide Market Forecast Revenue ($) by Applications (2020-2025)

Table Global Cyclophosphamide Market Forecast Revenue Share by Applications (2020-2025)

Figure Global Malignant Lymphoma Sales and Growth Rate (2015-2020)

Figure Global Malignant Lymphoma Price (2015-2020)

Figure Global Multiple Myeloma Sales and Growth Rate (2015-2020)

Figure Global Multiple Myeloma Price (2015-2020)

Figure Global Cyclophosphamide Market Revenue ($) and Growth Rate Forecast of Malignant Lymphoma (2020-2025)

Figure Global Cyclophosphamide Sales and Growth Rate Forecast of Malignant Lymphoma (2020-2025)

Figure Global Cyclophosphamide Market Revenue ($) and Growth Rate Forecast of Multiple Myeloma (2020-2025)

Figure Global Cyclophosphamide Sales and Growth Rate Forecast of Multiple Myeloma (2020-2025)

Figure Global Cyclophosphamide Sales and Growth Rate (2015-2020)

Table Global Cyclophosphamide Sales by Regions (2015-2020)

Table Global Cyclophosphamide Sales Market Share by Regions (2015-2020)

Figure Global Cyclophosphamide Sales Market Share by Regions in 2019

Figure Global Cyclophosphamide Revenue and Growth Rate (2015-2020)

Table Global Cyclophosphamide Revenue by Regions (2015-2020)

Table Global Cyclophosphamide Revenue Market Share by Regions (2015-2020)

Figure Global Cyclophosphamide Revenue Market Share by Regions in 2019

Table Global Cyclophosphamide Market Forecast Sales by Regions (2020-2025)

Table Global Cyclophosphamide Market Forecast Sales Share by Regions (2020-2025)

Table Global Cyclophosphamide Market Forecast Revenue ($) by Regions (2020-2025)

Table Global Cyclophosphamide Market Forecast Revenue Share by Regions (2020-2025)

Figure North America Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure North America Cyclophosphamide Market Revenue and Growth Rate (2015-2020)

Figure North America Cyclophosphamide Market Forecast Sales (2020-2025)

Figure North America Cyclophosphamide Market Forecast Revenue ($) (2020-2025)

Figure North America COVID-19 Status

Figure U.S. Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Canada Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Mexico Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Europe Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Europe Cyclophosphamide Market Revenue and Growth Rate (2015-2020)

Figure Europe Cyclophosphamide Market Forecast Sales (2020-2025)

Figure Europe Cyclophosphamide Market Forecast Revenue ($) (2020-2025)

Figure Europe COVID-19 Status

Figure Germany Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure United Kingdom Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure France Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Italy Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Spain Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Russia Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Cyclophosphamide Market Revenue and Growth Rate (2015-2020)

Figure Asia-Pacific Cyclophosphamide Market Forecast Sales (2020-2025)

Figure Asia-Pacific Cyclophosphamide Market Forecast Revenue ($) (2020-2025)

Figure Asia Pacific COVID-19 Status

Figure China Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Japan Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure South Korea Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Australia Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure India Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure South America Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure South America Cyclophosphamide Market Revenue and Growth Rate (2015-2020)

Figure South America Cyclophosphamide Market Forecast Sales (2020-2025)

Figure South America Cyclophosphamide Market Forecast Revenue ($) (2020-2025)

Figure Brazil Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Argentina Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Columbia Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Cyclophosphamide Market Revenue and Growth Rate (2015-2020)

Figure Middle East and Africa Cyclophosphamide Market Forecast Sales (2020-2025)

Figure Middle East and Africa Cyclophosphamide Market Forecast Revenue ($) (2020-2025)

Figure UAE Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure Egypt Cyclophosphamide Market Sales and Growth Rate (2015-2020)

Figure South Africa Cyclophosphamide Market Sales and Growth Rate (2015-2020)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390